Verona Pharma PLC (NAS:VRNA)
$ 30.01 -0.16 (-0.53%) Market Cap: 2.44 Bil Enterprise Value: 2.17 Bil PE Ratio: 0 PB Ratio: 14.42 GF Score: 29/100

Q1 2019 Verona Pharma PLC Earnings Call Transcript

May 07, 2019 / 12:00PM GMT
Release Date Price: $6.63 (+5.24%)
Operator

Greetings. Welcome to Verona First Quarter 2019 Earnings Conference Call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to Stephanie Carrington, Investor Relations. Thank you. You may begin.

Stephanie Carrington
ICR, LLC - SVP

Thank you, operator. Good morning or afternoon depending on where you are. And welcome to today's call to review Verona Pharma's results for the 3 months ended March 31, 2019.

On this call, I am joined today by Jan-Anders Karlsson, Chief Executive Officer; and Piers Morgan, Chief Financial Officer. I trust that you have seen the press release that was issued this morning before market opened. It includes the results for the 3 months ended March 31, 2019, as well as the operational update. If you have not, the press release is also available on the Investor Relations portion of Verona Pharma's website.

On today's call, Jan-Anders will first provide a clinical development and business update for the first quarter 2019. Piers will then review the company's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot